ETISENSE | Linksium
Back to portfolio


Incorporated startups

DECRO: Connected jacket

profilePhoto   Chloé Poyet
Linksium Contact Chloé Poyet +33 (0)6 46 57 42 17
profilePhoto   Timothé Flenet, CEO
ETISENSE Timothé Flenet, CEO +33 (0)4 37 53 96 18
Gilet cardiorespiratoire decro logiciel lasa


  • Simplifies the performance of respiratory physiology
  • Allows to obtain better measurements
  • Avoids surgery

Key words

  • Preclinical
  • Non-invasive
  • Unobtrusive research
  • Cardiac monitoring

Intellectual Property

  • 2 patents
  • 2 software
  • 5 knowhow

Partnerships & Rewards

  • 2019 French Deeptech Innovation Competition Winner




  • CNRS
  • UGA

Linksium Continuum

  • Maturation
  • Incubation
  • Acceleration


  • Incorporated startups


Whether for the study of physiological mechanisms or the evaluation of the effectiveness and safety of a new drug, animal experimentation is at the heart of the development process of new drugs.
With small laboratory mammals (guinea pigs, rats, etc.), scientists lack simple and rapid techniques that are less restrictive for both the experimenters and the animals.


Etisense has created and developed and is now marketing DECRO®, the first telemetric jacket for the non-invasive monitoring of cardiac and respiratory functions, together with the activities of rodents in their living conditions.
The system relies on high-resolution measurements of variations of the chest cavity. The raw data of the sensors are transmitted via a wireless link and then transformed into standard physiological parameters by intelligent software using advanced signal processing algorithms and original physiological models.
The physiological parameters are displayed in real time on a computer or tablet and can also be analysed later.


The main advantages of DECRO® are:

• Refinement of experimental procedures and reduction of the number of animals (Ethics)

• Preservation of the physiology of animals and access to extended measures (minimising stress, animals allowed to move freely)

• Simplicity and speed of use (no surgery, reduced technician time, etc.) enabling faster decision-making than with existing techniques

State of progress

DECRO® is developed by the company ETISENSE, created in spring 2018. The project has received maturation and incubation financing via Linksium and the LSI Carnot Institute. The first version of the product is in industrialization and orders have been honoured in public research.

ETISENSE has expertise in connected tissue and signal processing that can be extended beyond research applied to small laboratory animals.


The DECRO® jacket targets the following applications:

  • Safety tests of new drugs (safety toxicology and pharmacology)
  • Early screening of molecules
  • Monitoring of vital parameters (per and post-operative, monitoring of end points)
  • Basic research (cardiac, respiratory, neurological)